Literature DB >> 15852178

Complications of ultrasound guided percutaneous ethanol injection therapy of the thyroid and parathyroid glands.

P S Mauz1, M Stiegler, M Holderried, S Brosch.   

Abstract

OBJECTIVES: Since 1990 percutaneous ethanol injection therapy (PEIT) has been applied clinically as a treatment strategy for focal and diffuse autonomy of the thyroid, for cystic lesions and for ablation of parathyroid hyperplasia (PEA). There are some additional indications currently under consideration as for example inoperable advanced cancer of the thyroid. Since its inception PEIT and PEA have been regarded as an effective, inexpensive and low risk procedure.
MATERIAL AND METHODS: We discuss mild and severe complications of these methods reported in literature and the first case so far of a severe ethyl toxic necrosis of the larynx and adjacent skin in a patient treated with PEIT by a radiologist.
RESULTS: To date, no serious side effects have been reported in connection with these therapies. Some authors conclude that the side effects are in no way negligible and caution and routine should be exercised when using PEIT or PEA. Most complications have been transient in nature. The complication of ethyl toxic necrosis of the larynx was serious and the patient was admitted to hospital, treated conservatively and ten month later microsurgically. Voice thus could be restored to almost normal.
CONCLUSIONS: PEIT for focal and diffuse autonomy, for cystic lesions of the thyroid, for thyroid hyperplasia and PEA for parathyroid hyperplasia are methods which are inexpensive and can be performed on an ambulatory base. These are the methods of choice if surgical intervention or radioiodine therapies are not practicable out of medical reasons or by refusal of the patient. The patient must be informed about possible severe complications. The examiner should have substantial experience in these methods. If complications an early opinion of a specialist is required.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15852178     DOI: 10.1055/s-2005-857867

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  5 in total

1.  Long-term outcomes of ethanol injection therapy for locally recurrent papillary thyroid cancer.

Authors:  Soo Young Kim; Seok-Mo Kim; Hojin Chang; Bup-Woo Kim; Chi Young Lim; Yong Sang Lee; Hang-Seok Chang; Cheong Soo Park
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-29       Impact factor: 2.503

Review 2.  Parathyroid carcinoma: update and guidelines for management.

Authors:  Christina H Wei; Avital Harari
Journal:  Curr Treat Options Oncol       Date:  2012-03

3.  Ethanol ablation as a treatment strategy for benign cystic thyroid nodules: a comparison of the ethanol retention and aspiration techniques.

Authors:  Hye Sun Park; Younghee Yim; Jung Hwan Baek; Young Jun Choi; Young Kee Shong; Jeong Hyun Lee
Journal:  Ultrasonography       Date:  2018-08-01

4.  Efficacy Assessment of Ultrasound Guided Lauromacrogol Injection for Ablation of Benign Cystic and Predominantly Cystic Thyroid Nodules.

Authors:  Yijie Dong; Jianqiao Zhou; Zhenhua Liu; Ting Luo; Weiwei Zhan
Journal:  Front Pharmacol       Date:  2019-05-08       Impact factor: 5.810

5.  Management and Outcome of Parathyroid Carcinoma-Induced Primary Hyperparathyroidism: A Single-Centre Experience.

Authors:  Loredana De Pasquale; Antonio Mario Bulfamante; Giovanni Felisati; Luca Castellani; Giorgio Ghilardi; Alberto Maria Saibene
Journal:  Int J Endocrinol       Date:  2021-10-07       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.